The biology of Kit in disease and the application of pharmacogenetics

The Journal of Allergy and Clinical Immunology
Cem Akin, D D Metcalfe

Abstract

C-kit encodes a transmembrane protein with intrinsic tyrosine kinase activity, which functions as the receptor for stem cell factor. It is expressed on a variety of cell types, including mast cells, hematopoietic progenitor cells, melanocytes, germ cells, and gastrointestinal pacemaker cells. Mutations resulting in alteration of Kit function are associated with diseases involving each of these cells. Recent development of tyrosine kinase inhibitors led to their evaluation as novel therapies for diseases associated with Kit activation. This review will discuss the pathobiology of Kit in human disease, with a particular emphasis on implications for potential targeted treatment strategies in mast cell disease.

References

Jun 1, 1992·Experimental Cell Research·T IwamotoI Nakashima
Jul 1, 1991·The Journal of Experimental Medicine·M OgawaS Nishikawa
Nov 1, 1995·British Journal of Haematology·Y NakataY Satow
Mar 7, 1997·The Journal of Biological Chemistry·M A LemmonJ Schlessinger
Nov 20, 1997·Journal of Cellular Physiology·M Bar-Eli
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·B J LongleyY Ma
Jun 11, 1999·The American Journal of Pathology·Q TianC A Moskaluk
Dec 3, 1999·The International Journal of Biochemistry & Cell Biology·D Linnekin
Mar 7, 2000·The American Journal of Pathology·M L LuxJ A Fletcher
Sep 28, 2000·Reviews of Reproduction·M A DriancourtJ Smitz
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
May 30, 2001·Leukemia Research·P ValentJ M Bennett
Jun 14, 2001·Journal of Clinical Immunology·Y A MekoriD D Metcalfe
Nov 14, 2001·Lancet·A T van OosteromUNKNOWN European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichChristopher L Corless
May 29, 2002·Oncogene·Blanca Scheijen, James D Griffin
Jun 6, 2002·Lancet·Gerald J GleichJoseph H Butterfield
Jan 17, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Markku MiettinenJerzy Lasota
Feb 13, 2003·The Journal of Pathology·Mahmoud R HusseinGary S Wood
Feb 13, 2003·British Journal of Haematology·Faisel M Abu-DuhierJohn T Reilly
May 20, 2003·Pigment Cell Research·Bernhard Wehrle-Haller
May 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Gunhild SommerPeter Besmer

❮ Previous
Next ❯

Citations

Jun 6, 2007·Current Allergy and Asthma Reports·Susan I Hungness, Cem Akin
Apr 29, 2010·Current Allergy and Asthma Reports·Cem Akin
Jun 8, 2010·International Journal of Hematology·Lawrence B Afrin
Mar 23, 2005·Current Opinion in Cell Biology·Matthias P Wymann, Romina Marone
Jun 30, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jill A PooleRohit K Katial
Jul 10, 2013·Integrative Biology : Quantitative Biosciences From Nano to Macro·Amir ShamlooSarah Heilshorn
Aug 23, 2011·Pediatric Dermatology·Kristin KleeweinMartin Laimer
Jul 5, 2005·Acta Haematologica·Cem Akin
Aug 8, 2008·Blood·Dean D Metcalfe
Apr 4, 2006·American Journal of Veterinary Research·Regina ZavodovskayaCheryl A London
Dec 3, 2014·Annales de dermatologie et de vénéréologie·S Barete
May 10, 2008·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy·Anna Chiara PiscagliaAntonio Gasbarrini
Feb 24, 2015·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Oytun ErbasAltug Yavasoglu
Aug 22, 2007·Scandinavian Journal of Gastroenterology·Gerhard J MolderingsIvar Von Kügelgen
Jun 15, 2007·Critical Reviews in Biochemistry and Molecular Biology·Bénédicte CauweGhislain Opdenakker
Aug 30, 2014·The American Journal of the Medical Sciences·Lawrence B Afrin
Jun 7, 2011·The American Journal of the Medical Sciences·Lawrence B Afrin
Mar 23, 2011·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Lawrence B Afrin
Jun 10, 2009·Veterinary Immunology and Immunopathology·Emir HadzijusufovicPeter Valent
Jan 25, 2012·Obstetrics and Gynecology·Kendra D WatsonGerald W Volcheck
Aug 9, 2008·Veterinary Immunology and Immunopathology·Keitaro OhmoriKenichi Masuda
Apr 15, 2008·La Revue de médecine interne·S Georgin-LavialleO Hermine
Feb 20, 2007·Trends in Molecular Medicine·Shanti T Gangaram-PandayPaul de Vos
Apr 25, 2006·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Kristine Bjørndal SørensenAnnelise Krogdahl
Jan 25, 2006·Molecular Reproduction and Development·Abraham L Kierszenbaum
Aug 23, 2006·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Bin WangYoshiya Tanaka
Nov 23, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J M BrownD D Metcalfe
Jun 20, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·K VaaliK K Eklund
Jan 3, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A LewisP T Peachell
Jan 21, 2014·American Journal of Hematology·Thomas KristensenUNKNOWN Mastocytosis Centre, Odense University Hospital (MastOUH)
Apr 23, 2014·Alimentary Pharmacology & Therapeutics·N IorioF K Friedenberg
Jul 9, 2004·The Journal of Allergy and Clinical Immunology·Yoseph A Mekori
Nov 7, 2013·Experimental Hematology & Oncology·Lawrence B Afrin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis